DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | +3.4% | 2,078 | 0.0% | 0.15% | +7.8% |
| Q2 2023 | $498 | -4.8% | 2,078 | 0.0% | 0.14% | -9.6% |
| Q1 2023 | $523 | -5.1% | 2,078 | 0.0% | 0.16% | -8.2% |
| Q4 2022 | $551 | -99.9% | 2,078 | 0.0% | 0.17% | -7.1% |
| Q3 2022 | $536,000 | -5.5% | 2,078 | -7.1% | 0.18% | -0.5% |
| Q2 2022 | $567,000 | -15.5% | 2,238 | -2.2% | 0.18% | -5.6% |
| Q1 2022 | $671,000 | -10.8% | 2,288 | 0.0% | 0.20% | -4.9% |
| Q4 2021 | $752,000 | +8.0% | 2,288 | 0.0% | 0.20% | -1.0% |
| Q3 2021 | $696,000 | +13.4% | 2,288 | 0.0% | 0.21% | +11.3% |
| Q2 2021 | $614,000 | +14.3% | 2,288 | -4.2% | 0.19% | +7.5% |
| Q1 2021 | $537,000 | +1.3% | 2,388 | 0.0% | 0.17% | -6.0% |
| Q4 2020 | $530,000 | +3.1% | 2,388 | 0.0% | 0.18% | -8.5% |
| Q3 2020 | $514,000 | +21.8% | 2,388 | 0.0% | 0.20% | +14.9% |
| Q2 2020 | $422,000 | +27.9% | 2,388 | 0.0% | 0.18% | +5.4% |
| Q1 2020 | $330,000 | -9.8% | 2,388 | 0.0% | 0.17% | +21.2% |
| Q4 2019 | $366,000 | +4.9% | 2,388 | -1.2% | 0.14% | -0.7% |
| Q3 2019 | $349,000 | +1.2% | 2,417 | 0.0% | 0.14% | -1.4% |
| Q2 2019 | $345,000 | +8.2% | 2,417 | 0.0% | 0.14% | +5.3% |
| Q1 2019 | $319,000 | +28.1% | 2,417 | 0.0% | 0.13% | +11.8% |
| Q4 2018 | $249,000 | -5.0% | 2,417 | 0.0% | 0.12% | -0.8% |
| Q3 2018 | $262,000 | +10.1% | 2,417 | 0.0% | 0.12% | +2.6% |
| Q2 2018 | $238,000 | +0.8% | 2,417 | 0.0% | 0.12% | -2.5% |
| Q1 2018 | $236,000 | +5.4% | 2,417 | 0.0% | 0.12% | +7.1% |
| Q4 2017 | $224,000 | +8.2% | 2,417 | 0.0% | 0.11% | +5.7% |
| Q3 2017 | $207,000 | +2.0% | 2,417 | 0.0% | 0.11% | -3.6% |
| Q2 2017 | $203,000 | -1.5% | 2,417 | 0.0% | 0.11% | -1.8% |
| Q1 2017 | $206,000 | -15.6% | 2,417 | 0.0% | 0.11% | -24.3% |
| Q2 2016 | $244,000 | +6.6% | 2,417 | 0.0% | 0.15% | +3.5% |
| Q1 2016 | $229,000 | +2.2% | 2,417 | 0.0% | 0.14% | +2.9% |
| Q4 2015 | $224,000 | +9.3% | 2,417 | 0.0% | 0.14% | +3.0% |
| Q3 2015 | $205,000 | -19.9% | 2,417 | -19.4% | 0.14% | -16.7% |
| Q2 2015 | $256,000 | +0.8% | 3,000 | 0.0% | 0.16% | +0.6% |
| Q1 2015 | $254,000 | -1.2% | 3,000 | 0.0% | 0.16% | 0.0% |
| Q4 2014 | $257,000 | +13.2% | 3,000 | 0.0% | 0.16% | +5.2% |
| Q3 2014 | $227,000 | -3.8% | 3,000 | 0.0% | 0.15% | -6.1% |
| Q2 2014 | $236,000 | +4.9% | 3,000 | 0.0% | 0.16% | -1.2% |
| Q1 2014 | $225,000 | -2.6% | 3,000 | 0.0% | 0.16% | -7.3% |
| Q4 2013 | $231,000 | +11.6% | 3,000 | 0.0% | 0.18% | +1.7% |
| Q3 2013 | $207,000 | – | 3,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |